VERMILLION, INC. 12117 BEE CAVES ROAD, BUILDING THREE, SUITE 100 AUSTIN, TEXAS 78738Agreement to Reprice and Exercise Warrants • August 28th, 2017 • Vermillion, Inc. • In vitro & in vivo diagnostic substances • Delaware
This letter agreement sets forth the agreement between Vermillion, Inc., a Delaware corporation (the “Company”), and the undersigned (the “Holder”) regarding (a) an amendment to the exercise price of Warrant No. 2014-[___] (the “Original Warrant”) to purchase up to [______] shares (the “Warrant Shares”) of the Company’s common stock, par value $0.001 per share (“Common Stock”), which was initially issued to the Holder on December 23, 2014 (as amended hereby, the “Amended Warrant” and, the Amended Warrant, together with the Warrant Shares, the “Securities”), and (b) the Holder’s agreement to exercise in full or in part the Amended Warrant. The Original Warrant was issued pursuant to, and the Amended Warrant and the Warrant Shares will continue to be subject to, the terms and conditions of that certain Securities Purchase Agreement, dated December 19, 2014 (the “Securities Purchase Agreement”), by and among the Company, the Holder and each other person listed on Schedule I thereto.
